A large review found that people who stopped taking GLP-1 drugs regained weight nearly twice as fast as people who gave up ...

A new study found that patients returned to their original weight in just 1.7 years. The post People Who Go Off GLP-1s Are ...

The U.S. Food and Drug Administration approved the pill version of Wegovy on December 22, marking the first FDA-approved ...

In truth all the listed grocers enjoyed strong food sales this Christmas, but these were offset by issues elsewhere ...

As interest in GLP-1 medication grows, scammers are tricking consumers with fake alternatives. Here's how to spot them.

Jess Loren remembers loving the taste of Cap'n Crunch cereal. Coca-Cola. Snickers bars. But now, instead of a sweetness, "they taste bland," she says. Flavors are noticeably muted since she started a ...

The federal government is shifting more responsibilities to states, and states must prepare for greater costs in the Medicaid ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in record numbers, providers are warning of a troubling ripple effect: ...

The U.S. Food and Drug Administration just approved the pill form of weight-loss drug Wegovy for use in the U.S. The daily oral medication, made by Novo Nordisk, is the first of its kind used to treat ...

A major New Year’s resolution is weight loss and many people plan to use GLP-1 meds to help. But scammers are eager to steal your money and personal info in the process. Consumer Investigator Caresse ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making history again with the first FDA approval of a GLP-1 pill for weight loss.

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...